SpringWorks Therapeutics

SpringWorks Therapeutics is a clinical-stage biopharmaceutical company at the forefront of precision medicine, developing life-changing medicines for patients with severe rare diseases and cancer. We are actively building our portfolio of targeted oncology drugs and are currently advancing two lead product candidates into late-stage clinical trials. Our strategic approach involves partnerships with industry and academia to unlock the full potential of our portfolio and create more solutions for patients with cancer. Our tech stack supports a collaborative and data-driven approach. We utilize technologies like Google Analytics, Google Tag Manager, and WordPress for our website presence, ensuring we have the tools for effective communication, data collection, and content management. Our engineering culture fosters collaboration and innovation to tackle complex challenges. We encourage cross-functional team work and expect our teams to contribute to the evolution of the company. We prioritize a culture that fosters growth, ownership, and community. SpringWorks Therapeutics is a rapidly growing company with between 251 and 500 employees. We offer a supportive, remote-friendly work environment, allowing our employees to work from home within the United States. As a public company listed on NASDAQ (SWTX), we have multiple funding rounds, and we are excited about our continued growth trajectory. Our commitment to DE&I and providing best-in-class benefits demonstrates our commitment to our SpringWorkers.